ISRCTN91570009已完成未知
Enoxaparin - effective dosage for intensive care patients: a double-blinded, randomised clinical trial - part 2
Odense University Hospital (Denmark)0 个研究点目标入组 80 人开始时间: 2011年3月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Consecutive patients admitted to the ICU
- •2. Aged over 18 years, either sex
- •3. Minimum stay of greater than 24 hours
排除标准
- •1. Patients weighing less than 50 kg or greater than 90 kg
- •2. Bleeding diathesis
- •3. In need of an operation within the timeframe of the study
- •4. Pregnant
- •5. Requiring continuous veno-venous haemofiltration
研究者
相似试验
已完成
不适用
Effective prevention of blood clots in critically ill patientsVenous thromboembolismCirculatory SystemOther venous embolism and thrombosisISRCTN03037804Odense University Hospital (Denmark)80
进行中（未招募）
不适用
Enoksapariinin farmakokinetiikka tehohoitopotilaillaKriittisesti sairaita tehohoitopotilaitaMedDRA version: 14.1Level: LLTClassification code 10059115Term: Intensive care unit syndromeSystem Organ Class: 100000004873EUCTR2012-004599-21-FITAYS/teho-osasto
进行中（未招募）
1 期
Exoxaparin in hospitalized patients with moderate-severe COVID19Hospitalized adult patients with microbiologically confirmed moderate-severe COVID-19 infectionMedDRA version: 20.0Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: SOCClassification code 10038738Term: Respiratory, thoracic and mediastinal disordersSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2020-001308-40-ITALMA MATER STUDIORUM UNIVERSITà DI BOLOGNA100
进行中（未招募）
1 期
ENOXAPARIN AT PROPHYLACTIC OR THERAPEUTIC DOSES WITH MONITORING OF OUTCOMES IN SUBJECTS INFECTED WITH COVID-19SARS-CoV-2 related pneumoniaEUCTR2020-002214-40-ITASST FATEBENEFRATELLI SACCO300
招募中
不适用
Safety of enoxaparin in patients undergoing curative hepato-biliary-pancreatic cancer surgerySafety of enoxaparin in patients undergoing curative hepato-biliary-pancreatic cancer surgeryJPRN-UMIN000007761Graduate School of Medicine, Osaka University Department of Gastrointestinal Surgery150